Redhill Biopharma (Redhill Biopharma) Days Payable : 423.30 (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Redhill Biopharma Days Payable?

Redhill Biopharma's average Accounts Payable for the three months ended in Jun. 2023 was $3.74 Mil. Redhill Biopharma's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.81 Mil. Hence, Redhill Biopharma's Days Payable for the three months ended in Jun. 2023 was 423.30.

The historical rank and industry rank for Redhill Biopharma's Days Payable or its related term are showing as below:

RDHL' s Days Payable Range Over the Past 10 Years
Min: 66.81 Med: 280.63 Max: 606.56
Current: 66.81

During the past 13 years, Redhill Biopharma's highest Days Payable was 606.56. The lowest was 66.81. And the median was 280.63.

RDHL's Days Payable is ranked worse than
62.17% of 978 companies
in the Drug Manufacturers industry
Industry Median: 86.975 vs RDHL: 66.81

Redhill Biopharma's Days Payable increased from Jun. 2022 (51.12) to Jun. 2023 (423.30). It may suggest that Redhill Biopharma delayed paying its suppliers.

Redhill Biopharma Days Payable Historical Data

The historical data trend for Redhill Biopharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Days Payable Chart

Redhill Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

606.56

77.85

85.76

87.01

396.13

Redhill Biopharma Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															44.21	47.83	243.30	423.30	-

Competitive Comparison of Redhill Biopharma's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Redhill Biopharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redhill Biopharma's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redhill Biopharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Redhill Biopharma's Days Payable falls into.

Redhill Biopharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Redhill Biopharma's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (4.23	+	3.278)	/	2 )	/	3.459	*	365
=	3.754					/	3.459	*	365
=	396.13

Redhill Biopharma's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2023 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (4.366	+	3.112)	/	2 )	/	0.806	*	365 / 4
=	3.739					/	0.806	*	365 / 4
=	423.30

Redhill Biopharma Days Payable Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Redhill Biopharma (Redhill Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (NAS:RDHL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

2RH0:Germany 2RH0:Germany

Address

21 Ha’arba’a Street, Tel Aviv, ISR, 6473921

Website

https://www.redhillbio.com

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.